Skip to main content
Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.120
-0.040 (-1.85%)
At close: Apr 28, 2026, 4:00 PM EDT
2.120
0.00 (0.00%)
After-hours: Apr 28, 2026, 8:00 PM EDT

Protalix BioTherapeutics Revenue

In the year 2025, Protalix BioTherapeutics had annual revenue of $52.74M, down -1.23%. Protalix BioTherapeutics had revenue of $9.12M in the quarter ending December 31, 2025, a decrease of -49.93%.

Revenue (ttm)
$52.74M
Revenue Growth
-1.23%
P/S Ratio
3.24
Revenue / Employee
$233,381
Employees
226
Market Cap
170.81M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202552.74M-655.00K-1.23%
Dec 31, 202453.40M-12.10M-18.47%
Dec 31, 202365.49M17.86M37.48%
Dec 31, 202247.64M9.29M24.22%
Dec 31, 202138.35M-24.55M-39.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Black Diamond Therapeutics 70.00M
Precision BioSciences 34.26M
ProQR Therapeutics 19.19M
Tonix Pharmaceuticals Holding 13.11M
Korro Bio 6.39M
Cartesian Therapeutics 2.80M
Revenue Rankings

PLX News

More News